Feinstein DL - Search Results

1

Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.

Polak PE, Dull RO, Kalinin S, Sharp AJ, Ripper R, Weinberg G, Schwartz DE, Rubinstein I, Feinstein DL. Polak PE, et al. Among authors: feinstein dl. J Neuroinflammation. 2012 Dec 19;9:272. doi: 10.1186/1742-2094-9-272. J Neuroinflammation. 2012. PMID: 23253693 Free PMC article.

2

Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.

Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, Peters JM, Richardson J, Willson TM, Weinberg G, Feinstein DL. Polak PE, et al. Among authors: feinstein dl. J Neuroimmunol. 2005 Nov;168(1-2):65-75. doi: 10.1016/j.jneuroim.2005.07.006. Epub 2005 Aug 10. J Neuroimmunol. 2005. PMID: 16098614

3

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis.

Sharp AJ, Polak PE, Simonini V, Lin SX, Richardson JC, Bongarzone ER, Feinstein DL. Sharp AJ, et al. Among authors: feinstein dl. J Neuroinflammation. 2008 Aug 8;5:33. doi: 10.1186/1742-2094-5-33. J Neuroinflammation. 2008. PMID: 18691411 Free PMC article.

4

Increasing CNS noradrenaline reduces EAE severity.

Simonini MV, Polak PE, Sharp A, McGuire S, Galea E, Feinstein DL. Simonini MV, et al. Among authors: feinstein dl. J Neuroimmune Pharmacol. 2010 Jun;5(2):252-9. doi: 10.1007/s11481-009-9182-2. Epub 2009 Dec 4. J Neuroimmune Pharmacol. 2010. PMID: 19957206

5

Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis.

Polak PE, Kalinin S, Feinstein DL. Polak PE, et al. Among authors: feinstein dl. Brain. 2011 Mar;134(Pt 3):665-77. doi: 10.1093/brain/awq362. Epub 2011 Feb 4. Brain. 2011. PMID: 21297130 Free PMC article.

6

The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.

Polak PE, Kalinin S, Braun D, Sharp A, Lin SX, Feinstein DL. Polak PE, et al. Among authors: feinstein dl. J Neurochem. 2012 Apr;121(2):206-16. doi: 10.1111/j.1471-4159.2012.07673.x. Epub 2012 Feb 17. J Neurochem. 2012. PMID: 22288774 Free article.

7

The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.

Polak PE, Lin SX, Pelligrino D, Feinstein DL. Polak PE, et al. Among authors: feinstein dl. J Neuroimmunol. 2014 Nov 15;276(1-2):135-41. doi: 10.1016/j.jneuroim.2014.09.004. Epub 2014 Sep 16. J Neuroimmunol. 2014. PMID: 25242632

8

Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis.

Dupree JL, Polak PE, Hensley K, Pelligrino D, Feinstein DL. Dupree JL, et al. Among authors: feinstein dl. J Neurochem. 2015 Jul;134(2):302-14. doi: 10.1111/jnc.13114. Epub 2015 Apr 22. J Neurochem. 2015. PMID: 25846048 Free article.

9

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.

Kalinin S, Polak PE, Lin SX, Sakharkar AJ, Pandey SC, Feinstein DL. Kalinin S, et al. Among authors: feinstein dl. Neurobiol Aging. 2012 Aug;33(8):1651-63. doi: 10.1016/j.neurobiolaging.2011.04.012. Epub 2011 Jun 25. Neurobiol Aging. 2012. PMID: 21705113 Free PMC article.

10

Investigation of immunosuppressive mechanisms in a mouse glioma model.

Ksendzovsky A, Feinstein D, Zengou R, Sharp A, Polak P, Lichtor T, Glick RP. Ksendzovsky A, et al. J Neurooncol. 2009 May;93(1):107-14. doi: 10.1007/s11060-009-9884-6. Epub 2009 May 9. J Neurooncol. 2009. PMID: 19430886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page